About Secoya Technologies

Secoya Technologies, a spin-off of the Université Libre de Bruxelles launched in September 2019, develops unique technologies and equipment for the manufacturing of (bio)-pharmaceutical products. The core principle is to adapt industrial process equipment to the best scale, with the objective to optimize and better control production processes. This principle is applied to four process operations: crystallisation, micro-encapsulation, pervaporation and chemical synthesis.

The smart combination of these complementary technologies offers a unique solution on the market. Based in Louvain-La-Neuve, close to a rich ecosystem of pharma / biotech industries, the company is supported today by strong clients who helps improve the technology, and has the ambition to scale up internationally.

Our story


Secoya launched the InstaDrop! By its conception, this bench equipment allows the easy control of flow and particle size. And as it includes our 𝗥𝗮𝘆𝗱𝗿𝗼𝗽® technology, the 𝗜𝗻𝘀𝘁𝗮𝗗𝗥𝗢𝗣 is perfectly suited for bead and capsule microencapsulation, preformulation screening and small batch production.


Secoya Technologies raised €1M to commercialize its next-gen microfluidic equipment. This milestone allowed Secoya to move to a new level of growth while having a better knowledge of its customers and potential markets. These resources were indeed allocated in a relevant way to our commercial deployment and to the operational reinforcement required to support our development.


Secoya concluded its first contracts with major actors in the pharmaceutical industry, confirming the interests of our technologies. In parallel, Secoya performed internal projects to demonstrate further these benefits and in developing upscaling solutions for high quality industrial production


In October 2019, after raising funds from private investors, Secoya moved into its new headquarters gathering offices and laboratories within the scientific park of Louvain-la-Neuve, 20 minutes from Brussels. This is an ideal location, in the midst of a vibrant ecosystem of cutting-edge companies active in the fields of biotechnology and pharmaceuticals, and at the heart of a solid network of partners (precision mechanics, automation, engineering, imaging…) that is crucial to the development of its activities.


To successfully complete this project, they teamed up with a business manager and two “legal and investment” profiles who also became co-founders of the company. The interest expressed by certain major players in the pharmaceutical industry for this “multitechnological” company capable of apprehending in a holistic way the complex issues of drug manufacturing quickly confirmed the pertinence of this project. The company was not even been created when the first development contracts and equipment sales started being negotiated.


In 2018, the idea to give business value to these results within a single structure came to the mind of the future founders of Secoya. Their objective? To offer innovative and unique solutions to the pharmaceutical industry by gathering complementary expertise and technologies within one single entity.


Since 2012, the TIPs laboratory (Transfer, Interface and Processes) at the Université Libre de Bruxelles has been involved in various R&D projects that have led to the development of new technologies related to flow control in milli/microfluidic structures.

The team

Bertrand Loriers


Adrien Dewandre

Technology Lead – Emulsification & Droplet generation

Jean Septavaux

Technology Lead – Pervaporation & Process Intensification

Bart Rimez

Technology Lead – Crystallization

Marie Mettler

R&D Engineer

Benoit Scheid


Alex Vandekerckhove


Jean-Charles Snoy


Board of directors

Stéphanie Hoffmann
Cédric Szpirer
José Castillo
Jean-Marie Solvay